Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and NEX listed companies, has recently advised Integumen Plc (“Integumen”) on its £2.25 million AIM IPO. Admission took place on 5 April 2017 at which point the company’s market capitalisation was £8.25 million. 

Integumen is a personal health care company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.

The proceeds will enable Integumen to fund the development and sales and marketing of its products in addition to providing working capital.

Jeffreys Henry LLP acted as the Reporting Accountant in respect of the AIM IPO.